25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      PP4‐dependent HDAC3 dephosphorylation discriminates between axonal regeneration and regenerative failure

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The molecular mechanisms discriminating between regenerative failure and success remain elusive. While a regeneration‐competent peripheral nerve injury mounts a regenerative gene expression response in bipolar dorsal root ganglia ( DRG) sensory neurons, a regeneration‐incompetent central spinal cord injury does not. This dichotomic response offers a unique opportunity to investigate the fundamental biological mechanisms underpinning regenerative ability. Following a pharmacological screen with small‐molecule inhibitors targeting key epigenetic enzymes in DRG neurons, we identified HDAC3 signalling as a novel candidate brake to axonal regenerative growth. In vivo, we determined that only a regenerative peripheral but not a central spinal injury induces an increase in calcium, which activates protein phosphatase 4 that in turn dephosphorylates HDAC3, thus impairing its activity and enhancing histone acetylation. Bioinformatics analysis of ex vivo H3K9ac Ch IPseq and RNAseq from DRG followed by promoter acetylation and protein expression studies implicated HDAC3 in the regulation of multiple regenerative pathways. Finally, genetic or pharmacological HDAC3 inhibition overcame regenerative failure of sensory axons following spinal cord injury. Together, these data indicate that PP4‐dependent HDAC3 dephosphorylation discriminates between axonal regeneration and regenerative failure.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: not found
          • Article: not found

          Reactive oxygen species regulate axonal regeneration through the release of exosomal NADPH oxidase 2 complexes into injured axons

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury.

            Regeneration is abortive following adult mammalian CNS injury. We have investigated whether increasing the intrinsic growth state of primary sensory neurons by a conditioning peripheral nerve lesion increases regrowth of their central axons. After dorsal column lesions, all fibers stop at the injury site. Animals with a peripheral axotomy concomitant with the central lesion show axonal growth into the lesion but not into the spinal cord above the lesion. A preconditioning lesion 1 or 2 weeks prior to the dorsal column injury results in growth into the spinal cord above the lesion. In vitro, the growth capacity of DRG neurite is also increased following preconditioning lesions. The intrinsic growth state of injured neurons is, therefore, a key determinant for central regeneration.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HDAC3: taking the SMRT-N-CoRrect road to repression.

              Known histone deacetylases (HDACs) are divided into different classes, and HDAC3 belongs to Class I. Through forming multiprotein complexes with the corepressors SMRT and N-CoR, HDAC3 regulates the transcription of a plethora of genes. A growing list of nonhistone substrates extends the role of HDAC3 beyond transcriptional repression. Here, we review data on the composition, regulation and mechanism of action of the SMRT/N-CoR-HDAC3 complexes and provide several examples of nontranscriptional functions, to illustrate the wide variety of physiological processes affected by this deacetylase. Furthermore, we discuss the implication of HDAC3 in cancer, focusing on leukemia. We conclude with some thoughts about the potential therapeutic efficacies of HDAC3 activity modulation.
                Bookmark

                Author and article information

                Contributors
                s.di-giovanni@imperial.ac.uk
                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                22 May 2019
                01 July 2019
                : 38
                : 13 ( doiID: 10.1002/embj.v38.13 )
                : e101032
                Affiliations
                [ 1 ] Department of Medicine Division of Brain Sciences Molecular Neuroregeneration Imperial College London London UK
                [ 2 ] Molecular and Cellular Neurobiotechnology Institute for Bioengineering of Catalonia (IBEC) Parc Científic de Barcelona Barcelona Spain
                [ 3 ] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona Spain
                [ 4 ] Department of Cell Biology, Physiology and Immunology Universitat de Barcelona Barcelona Spain
                [ 5 ] Institute of Neuroscience University of Barcelona Barcelona Spain
                [ 6 ] Laboratory for NeuroRegeneration and Repair Center for Neurology Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany
                [ 7 ] Graduate School for Cellular and Molecular Neuroscience University of Tuebingen Tuebingen Germany
                [ 8 ] The Miami Project to Cure Paralysis Department of Neurological Surgery Miller School of Medicine University of Miami Miami FL USA
                [ 9 ] Center for the Neurobiology of Learning & Memory Department of Neurobiology & Behavior University of California Irvine CA USA
                [ 10 ] Spinal Cord Injury Center University Hospital Heidelberg Heidelberg Germany
                Author notes
                [*] [* ]Corresponding author. Tel: +44 020 759 43178; E‐mail: s.di-giovanni@ 123456imperial.ac.uk
                [†]

                These authors contributed equally to this work

                Author information
                https://orcid.org/0000-0003-3550-7576
                https://orcid.org/0000-0003-3154-5399
                Article
                PMC6600644 PMC6600644 6600644 EMBJ2018101032
                10.15252/embj.2018101032
                6600644
                31268609
                cd79cd28-68a5-4b30-a3d6-3c02202ef249
                © 2019 The Authors
                History
                : 29 October 2018
                : 15 April 2019
                : 17 April 2019
                Page count
                Figures: 13, Tables: 1, Pages: 20, Words: 13986
                Funding
                Funded by: Rosetrees Trust
                Funded by: Henry Smith Charity
                Funded by: Wings for Life (Wings for Life United Kingdom)
                Funded by: National Institute for Health Research (NIHR)
                Funded by: Imperial Biomedical Research Centre (SDG)
                Funded by: the Spanish Ministry of Economy, Industry and Competitiveness
                Award ID: BFU2015‐67777‐R
                Award ID: IJCI‐2016‐30783
                Categories
                Article
                Articles
                Custom metadata
                2.0
                embj2018101032
                01 July 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:01.07.2019

                HDAC3,calcium,Neuroscience,Signal Transduction,spinal cord injury,nerve regeneration,transcription

                Comments

                Comment on this article